Fusion Appoints Corey Watton as President and CEO

1 year ago

The company's former CFO will steer the company in its next chapterOMAHA, NE / ACCESSWIRE / September 11, 2023 /…

Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing on the CSE

1 year ago

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - Safe Supply Streaming Co. Ltd. ("Safe Supply" or the "Company") and…

Cloud DX Announces Closing of $3,546,000 Private Placement of Secured Convertible Debentures, and Amendments to Existing Unsecured Convertible Debentures and Warrant Repricing

1 year ago

KITCHENER, ON / ACCESSWIRE / September 11, 2023 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) (OTCQB:CDXFF), is…

Healthcare Leadership Education Provider Generation Leader Announces the Launch of Five New Courses, Limited Time Tuition Discount

1 year ago

MIDDLESEX, UK / ACCESSWIRE / September 11, 2023 / Generation Leader, the only leadership course provider certified by the 3…

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

1 year ago

Conservative care private practice owners can leverage Breakthrough's exclusive marketing campaigns to promote Enovis™ Corporation's innovative therapeutic technologies directly to…

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

1 year ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,…

Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

1 year ago

Halifax, Nova Scotia--(Newsfile Corp. - September 11, 2023) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")…

NervGen Pharma to Present at 2023 International Spinal Research Trust Network Meeting

1 year ago

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a…

Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference

1 year ago

Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer…